News | News By Subject | News by Disease News By Date | Search News

Cervical cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Death Forces FDA to Place Clinical Hold on Advaxis (ADXS) Cancer Drug     10/8/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co. (MRK)'s Gardasil     8/29/2014
San Diego Startup, Hera Therapeutics, Unveils Drug For Viral Infections Tied To Cervical Cancer     8/25/2014
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer     8/15/2014
Roche (RHHBY)'s Avastin Wins Priority Review For Cervical Cancer     7/15/2014
Pfizer Inc. (PFE) Takes Its Shot at a Vaccine for Evasive MRSA Superbug     5/23/2013
Inovio Pharmaceuticals (INO)'s Cervical Cancer Vaccine Shows Early Promise     10/12/2012
Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer     11/9/2011
Merck & Co., Inc. (MRK) Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan     7/1/2011
Merck & Co., Inc. (MRK)'s Gardasil Cuts Rate of Cervical Abnormalities     6/20/2011
Enzo Biochem (ENZ)’s Clinical Lab Acquires Marketing Rights to IncellDx, Inc.'s Unique, More Effective Diagnostic Test for Cervical Cancer     6/10/2011

News from Around the Web
Israeli Medical Company Hopes To Save Thousands Of Women’s Lives Per Year, Illumigyn Reveals     5/16/2016
HPV Infection Can Be Identified In Self-Collected Vaginal Swabs, University of New South Wales Study     5/2/2016
Cervical Cancer Screening With A Cellphone     10/30/2015
In Cervical Cancer Fight, 1 Shot Could be Enough, Study Published in Cancer Prevention Research Reveals     11/4/2013
HIV Drug Could Prevent Cervical Cancer, University of Manchester Study     5/3/2011
Oral Sex linked to Cancer Risk, Ohio State University Study Finds     2/23/2011
Male Circumcision Cuts Women's Cervical Cancer Risk, Johns Hopkins University Study     1/7/2011
Breast Cancer Drugs May Fight Cervical Cancer, University of Wisconsin-Madison Study     11/10/2009
Old, New Pap Methods Equally Good, Radboud University Nijmegen Medical Centre Study Finds     10/28/2009
Giving Gardasil to Boys Not Worth the Cost, Harvard School of Public Health Study     10/9/2009
Few Side Effects Found From Radiation Treatment Given After Prostate Cancer Surgery, Mayo Clinic Study     9/29/2009
Merck & Co., Inc. (MRK)'s Cervical Cancer Vaccine Benefits Older Women, Colombian Study     6/2/2009
New Technique May Improve Early Cervical Cancer Treatment, University of Leipzig Study     6/2/2009
Broad-Spectrum Cervical Cancer Vaccine Shows Promise, Johns Hopkins University Study     5/27/2009
Wart Virus Makes For Less Deadly Cancer, University of Chicago Study     5/15/2009

Press Releases
Results Of Cervical Cancer Study Sponsored By ISA Pharmaceuticals To Be Presented At ASCO-SITC     2/17/2017
Advaxis (ADXS) Release: GOG-0265 Study In Metastatic Cervical Cancer Selected For Late-Breaking Data Presentation At The Society Of Gynecologic Oncology’s Annual Meeting On Women’s Cancer     1/30/2017
Yaohua Medical Instrument Inks Agreement For Cervical Cancer Scan In China     1/30/2017
Advaxis (ADXS) Release: New Published Research Reveals That Cervical Cancer Mortality Rates May Be Significantly Higher In The United States Than Previously Reported     1/25/2017
Guided Therapeutics Release: Company Enters Into Luviva Advanced Cervical Scan Manufacturing And License Agreement For China     1/25/2017
Regen BioPharma Discusses A Recent Important Discovery Of NR2F6 In Human Cervical Cancer     12/8/2016
Advaxis (ADXS) Initiates Combination Portion Of Phase I/II Study With Merck & Co. (MRK)     10/20/2016
Cincinnati Children's Hospital Medical Center Release: Study Suggests HPV Vaccine Could Have Substantial Impact On Rates Of Cervical Cancers     9/21/2016
Immune Therapeutics, Through Its Wholly Owned Subsidiary TNI BioTech, Initiates Clinical Trial In Malawi With LDN For The Prevention Of Cervical Cancer     8/24/2016
Advaxis (ADXS) Release: Phase I/II Combination Trial Of AXAL And Durvalumab Completes Second Dose-Escalation Cohort     7/26/2016
Guided Therapeutics Ships Additional Luviva Advanced Cervical Scan Systems And Disposables To Bangladesh     7/26/2016
Advaxis (ADXS)’ AXAL Receives Fast Track Designation By The FDA As Adjuvant Therapy For High-Risk Locally Advanced Cervical Cancer Patients     7/21/2016
Guided Therapeutics Sells First LuViva Advanced Cervical Scan To Russia     7/21/2016
Genomic Vision Is Accelerating Its Clinical Trial In Cervical Cancer With An Additional Study In The Czech Republic     7/20/2016
Cepheid (CPHD) Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening     7/12/2016

//-->